Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
Key result
Human induced pluripotent stem cell-derived cardiomyocytes successfully recapitulate the disease phenotypes of Mendelian cardiac arrhythmia syndromes, providing a novel in vitro model for studying disease mechanisms.
Population
Human induced pluripotent stem cell derived cardiomyocytes modeling primary Mendelian cardiac arrhythmia…
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May accelerate preclinical arrhythmia research; leaves open clinical translation pending validation.
Structured PICO
P
Population
Human induced pluripotent stem cell (hiPSC) derived cardiomyocytes modeling primary Mendelian cardiac arrhythmia syndromes (including LQT1, LQT2, LQT3-Brugada Syndrome, LQT8/Timothy syndrome, and CPVT)
I
Intervention
Disease modeling using induced pluripotent stem cell (iPSC) technology
O
Outcome
Recapitulation of disease phenotype and insight into cardiac pathophysiology
Human iPSC-derived cardiomyocytes serve as effective in vitro models that recapitulate the phenotypes of primary Mendelian arrhythmia syndromes, facilitating the study of disease mechanisms and drug development.
Limitations
- hiPSC-CMs have an immature ultrastructure lacking t-tubules, leading to poor coupling between calcium influx and release.
- hiPSC-CMs often exhibit spontaneous activity and a less negative maximum diastolic potential compared to native adult ventricular cardiomyocytes.
- The action potential upstroke velocity in hiPSC-CMs is extremely low compared to freshly isolated human ventricular cardiomyocytes.
Cite This Study
Hoekstra et al. (2012) conducted a review in Inherited cardiac arrhythmias (e.g., LQTS, Brugada Syndrome, CPVT). Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) was evaluated. Human induced pluripotent stem cell-derived cardiomyocytes successfully recapitulate the disease phenotypes of Mendelian cardiac arrhythmia syndromes, providing a novel in vitro model for studying disease mechanisms.